Td Asset Management Inc Arcutis Biotherapeutics, Inc. Transaction History

Td Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$14.38 - $22.79 $516,529 - $818,616	-35,920 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$14.98 - $25.5 $81,041 - $137,955	5,410 Added 17.73%	35,920 $745,000
Q2 2021 Aug 11, 2021	SELL	$24.42 - $34.75 $76,800 - $109,288	-3,145 Reduced 9.34%	30,510 $712,000
Q1 2021 May 14, 2021	BUY	$24.47 - $36.98 $614,197 - $928,197	25,100 Added 293.4%	33,655 $974,000
Q4 2020 Feb 16, 2021	SELL	$17.82 - $31.73 $212,396 - $378,189	-11,919 Reduced 58.22%	8,555 $241,000
Q1 2020 May 15, 2020	BUY	$18.5 - $36.9 $378,769 - $755,490	20,474 New	20,474 $610,000

193

127M

5.43M

257K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $560M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.